← Back to Search

Procedure

Balloon Dilation for Eustachian Tube Dysfunction

N/A
Recruiting
Led By Justin Lui, MD, FRCSC
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks, 12 weeks, 24 weeks, and 52 weeks post-intervention

Summary

This trial is testing a procedure called balloon dilation of the eustachian tube for adults with ear pressure problems that haven't improved with other treatments. The procedure uses a small balloon to widen the eustachian tube, helping it work better and reduce symptoms. Balloon dilation of the eustachian tube (BDET) is a commonly performed procedure.

Who is the study for?
This trial is for individuals with persistent eustachian tube dysfunction who haven't improved after using nasal sprays or decongestants, or those experiencing barotitis media symptoms regularly. Participants must have documented ear drum movement issues and a history of related symptoms like ear pain, pressure, hearing changes, tinnitus, or vertigo.
What is being tested?
The study tests if balloon dilation of the eustachian tube is more effective than a sham (placebo) procedure in treating eustachian tube dysfunction. Patients will be randomly assigned to one of the procedures and followed up with various assessments over a year.
What are the potential side effects?
While re-confirming safety is part of this study's goals, potential side effects may include discomfort during the procedure, temporary hearing changes or dizziness post-procedure, and possible risk of infection similar to other ear interventions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks, 12 weeks, 24 weeks, and 52 weeks post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks, 12 weeks, 24 weeks, and 52 weeks post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in mean Eustachian Tube Dysfunction Questionnaire (ETDQ7) score
Change in symptoms (ad hoc baro-challenge ETDD symptom questionnaire)
Secondary study objectives
Ad hoc work/activity impairment questionnaire score
Change in audiogram (pure tone average thresholds)
Change in tympanogram type and pressure at peak compliance
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Balloon dilation of eustachian tubeExperimental Treatment1 Intervention
These patient will undergo balloon dilation dilation of the eustachian tube.
Group II: Sham procedurePlacebo Group1 Intervention
These patients will undergo a sham procedure, where the motions of balloon dilation of the eustachian tube will be simulated.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Eustachian Tube Dysfunction (ETD) include nasal steroid sprays, decongestants, and ear tube placement. Nasal steroid sprays and decongestants aim to reduce mucosal edema and inflammation, thereby improving the patency of the eustachian tube. Ear tube placement helps to ventilate the middle ear and equalize pressure. Balloon dilation of the eustachian tube, a newer treatment, mechanically widens the eustachian tube to improve its function and alleviate dysfunction. This is particularly important for ETD patients as it directly addresses the structural issues causing the dysfunction, potentially providing more effective and lasting relief compared to other treatments.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
810 Previous Clinical Trials
886,239 Total Patients Enrolled
Justin Lui, MD, FRCSCPrincipal InvestigatorUniversity of Calgary
~31 spots leftby Dec 2025